Joharchi, Khojasteh http://orcid.org/0000-0001-8146-8200
Memari, Moosareza
Azargashb, Eznollah
Saadat, Navid
Funding for this research was provided by:
Shahid Beheshti University of Medical Sciences (13/587, 16077)
Article History
Received: 12 January 2019
Accepted: 29 July 2019
First Online: 13 August 2019
Change Date: 13 September 2019
Change Type: Correction
Change Details: The article Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial, written by Khojasteh Joharchi, Moosareza Memari, Eznollah Azargashb, and Navid Saadat, was originally published.
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: This study was approved by the ethics committee of SBUMS (ethical code: IR.SBMU.MSP.REC.1395.41) and registered in the Iranian Registry of Clinical Trials website: ExternalRef removed and the registration number is: IRCT2017012932277N1.